Bionik Laboratories Corp
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; In… Read more
Bionik Laboratories Corp (BNKL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2023: 0.461x
Based on the latest financial reports, Bionik Laboratories Corp (BNKL) has a cash flow conversion efficiency ratio of 0.461x as of March 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-756.94K) by net assets ($-1.64 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bionik Laboratories Corp - Cash Flow Conversion Efficiency Trend (2012–2023)
This chart illustrates how Bionik Laboratories Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bionik Laboratories Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bionik Laboratories Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
086460
KO:086460
|
N/A |
|
Brain Scientific Inc
PINK:BRSF
|
-0.288x |
|
Alina Holdings PLC
LSE:ALNA
|
-0.041x |
|
Odel PLC
CM:ODELN0000
|
N/A |
|
NEW VISION PRINTING AND PUBLISHING COMPANY LTD
USE:NVL
|
N/A |
|
Metro One Telecommunications Inc
PINK:WOWI
|
0.047x |
|
MITRABAHTERA
BE:MTI
|
N/A |
|
XIANA MINING
MU:DO51
|
0.002x |
Annual Cash Flow Conversion Efficiency for Bionik Laboratories Corp (2012–2023)
The table below shows the annual cash flow conversion efficiency of Bionik Laboratories Corp from 2012 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-03-31 | $-1.64 Million | $-3.39 Million | 2.065x | +245.73% |
| 2022-03-31 | $2.93 Million | $-4.15 Million | -1.417x | -0.53% |
| 2021-03-31 | $3.28 Million | $-4.62 Million | -1.409x | -107.06% |
| 2020-03-31 | $13.32 Million | $-9.06 Million | -0.681x | -102.05% |
| 2019-03-31 | $27.41 Million | $-9.23 Million | -0.337x | +10.61% |
| 2018-03-31 | $20.46 Million | $-7.71 Million | -0.377x | -24.98% |
| 2017-03-31 | $23.19 Million | $-6.99 Million | -0.302x | +98.32% |
| 2016-03-31 | $263.91K | $-4.75 Million | -17.991x | -283.29% |
| 2015-12-31 | $977.99K | $-4.59 Million | -4.694x | -1498.37% |
| 2015-03-31 | $-39.34K | $-13.20K | 0.336x | -77.46% |
| 2014-03-31 | $-9.81K | $-14.61K | 1.489x | +160.89% |
| 2013-03-31 | $3.30K | $-8.07K | -2.446x | -252.38% |
| 2012-03-31 | $6.12K | $-4.25K | -0.694x | -- |